Forgent Power Solutions Inc. Class A Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Forgent Power Solutions Inc. Class A Common Stock trades at $31.61 (market cap $8.98B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: Forgent Power Solutions Inc. Class A Common Stock is the larger of the two by market cap, and Forgent Power Solutions Inc. Class A Common Stock is more actively traded (7,398,217 versus 2,027,457). Which is the better fit depends on your goals — on Pluang, investors hold Forgent Power Solutions Inc. Class A Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| FPS | IONS | |
|---|---|---|
Market Cap | $8.98B | $7.10B |
Volume | 7,398,217 | 2,027,457 |
Sector | Industrials | Health |
52-Week High | $64.59 | $86.50 |
52-Week Low | $27.97 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.58B | $6.66B |
Signals from Pluang's Aura AI — not financial advice
Forgent Power Solutions (FPS) trades at $36.17, down 2.48% on the day, following a strong earnings-driven rally. The stock shows neutral technical signals with support at $35 and resistance at $37. Recent Q2 2026 earnings beat expectations with EPS of $0.25 versus $0.24 expected, continuing a pattern of quarterly outperformance. The company reported record $3 billion backlog and strong data center demand driving growth.
FPS presents significant upside potential with analyst consensus target of $55.20 (52.9% upside) and 85.7% buy ratings. However, high valuation multiples (P/E 120.57, P/S 6.21) and negative 2025 net income of -$6.17M create valuation concerns. Key risks include execution on $3B backlog and potential overvaluation amid AI infrastructure hype.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Forgent Power Solutions designs and manufactures electrical distribution equipment, including transformers, switchgear, transfer switches, and prefabricated power systems, for data centers, the power grid, and industrial facilities, manufacturing across multiple product categories in-house through a network of manufacturing campuses in US.
Read more on FPS →Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →